Clara Marco‐Marín

850 total citations
20 papers, 539 citations indexed

About

Clara Marco‐Marín is a scholar working on Molecular Biology, Materials Chemistry and Clinical Biochemistry. According to data from OpenAlex, Clara Marco‐Marín has authored 20 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Materials Chemistry and 5 papers in Clinical Biochemistry. Recurrent topics in Clara Marco‐Marín's work include Biochemical and Molecular Research (9 papers), Enzyme Structure and Function (6 papers) and Metabolism and Genetic Disorders (5 papers). Clara Marco‐Marín is often cited by papers focused on Biochemical and Molecular Research (9 papers), Enzyme Structure and Function (6 papers) and Metabolism and Genetic Disorders (5 papers). Clara Marco‐Marín collaborates with scholars based in Spain, Italy and Germany. Clara Marco‐Marín's co-authors include Vicente Rubio, F. Gil-Ortiz, J.L. Llacer, Ignacio Fita, Asunción Contreras, Karl Forchhammer, Rafaël Maldonado, Santiago Ramón‐Maiques, E. Riudor and Isabel Pérez‐Arellano and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Molecular Biology and FEBS Letters.

In The Last Decade

Clara Marco‐Marín

20 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Clara Marco‐Marín Spain 13 411 131 116 105 73 20 539
Laurence Prunetti United States 12 337 0.8× 80 0.6× 84 0.7× 43 0.4× 69 0.9× 18 479
Carmen Brizio Italy 15 604 1.5× 92 0.7× 302 2.6× 158 1.5× 33 0.5× 20 763
Teresa Anna Giancaspero Italy 15 519 1.3× 78 0.6× 243 2.1× 124 1.2× 27 0.4× 18 725
Annie Glatigny France 12 410 1.0× 85 0.6× 40 0.3× 16 0.2× 43 0.6× 18 537
Florian Haase United States 9 272 0.7× 74 0.6× 32 0.3× 47 0.4× 26 0.4× 11 441
Nadia Terziyska Germany 10 976 2.4× 38 0.3× 195 1.7× 41 0.4× 29 0.4× 11 1.1k
Hilary Lewis United Kingdom 10 515 1.3× 123 0.9× 347 3.0× 485 4.6× 123 1.7× 12 888
Theodore C. Y. Lo Canada 17 514 1.3× 64 0.5× 86 0.7× 128 1.2× 119 1.6× 44 737
A L Fimmel Australia 15 569 1.4× 63 0.5× 38 0.3× 33 0.3× 102 1.4× 24 669
Mirco Steger Germany 11 684 1.7× 22 0.2× 123 1.1× 35 0.3× 30 0.4× 14 819

Countries citing papers authored by Clara Marco‐Marín

Since Specialization
Citations

This map shows the geographic impact of Clara Marco‐Marín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clara Marco‐Marín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clara Marco‐Marín more than expected).

Fields of papers citing papers by Clara Marco‐Marín

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clara Marco‐Marín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clara Marco‐Marín. The network helps show where Clara Marco‐Marín may publish in the future.

Co-authorship network of co-authors of Clara Marco‐Marín

This figure shows the co-authorship network connecting the top 25 collaborators of Clara Marco‐Marín. A scholar is included among the top collaborators of Clara Marco‐Marín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clara Marco‐Marín. Clara Marco‐Marín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martínez‐Rubio, Dolores, Clara Marco‐Marín, Vincenzo Lupo, et al.. (2023). Genetic Heterogeneity Underlying Phenotypes with Early-Onset Cerebellar Atrophy. International Journal of Molecular Sciences. 24(22). 16400–16400. 3 indexed citations
2.
Lence, Emilio, Begoña Gracia, José A. Aı́nsa, et al.. (2022). Discovery of 3H-pyrrolo[2,3-c]quinolines with activity against Mycobacterium tuberculosis by allosteric inhibition of the glutamate-5-kinase enzyme. European Journal of Medicinal Chemistry. 232. 114206–114206. 12 indexed citations
3.
Martínez‐Rubio, Dolores, Clara Marco‐Marín, Alison L. Jenkins, et al.. (2022). Protein misfolding and clearance in the pathogenesis of a new infantile onset ataxia caused by mutations in PRDX3. Human Molecular Genetics. 31(22). 3897–3913. 9 indexed citations
4.
Vílchez, Juan J., Marina Frasquet, Nuria Muelas, et al.. (2022). A novel TRMT5 mutation causes a complex inherited neuropathy syndrome: The role of nerve pathology in defining a demyelinating neuropathy. Neuropathology and Applied Neurobiology. 48(5). e12817–e12817. 8 indexed citations
5.
Marco‐Marín, Clara, et al.. (2020). Δ1‐Pyrroline‐5‐carboxylate synthetase deficiency: An emergent multifaceted urea cycle‐related disorder. Journal of Inherited Metabolic Disease. 43(4). 657–670. 20 indexed citations
6.
Selim, Khaled A., Clara Marco‐Marín, Vikram Alva, et al.. (2020). Functional and structural characterization of PII‐like protein CutA does not support involvement in heavy metal tolerance and hints at a small‐molecule carrying/signaling role. FEBS Journal. 288(4). 1142–1162. 11 indexed citations
7.
Magini, Pamela, Clara Marco‐Marín, Diego Martinelli, et al.. (2019). P5CS expression study in a new family with ALDH18A1‐associated hereditary spastic paraplegia SPG9. Annals of Clinical and Translational Neurology. 6(8). 1533–1540. 14 indexed citations
8.
Llacer, J.L., et al.. (2018). The PII-NAGK-PipX-NtcA Regulatory Axis of Cyanobacteria: A Tale of Changing Partners, Allosteric Effectors and Non-covalent Interactions. Frontiers in Molecular Biosciences. 5. 91–91. 37 indexed citations
9.
Collado, Antonio, Clara Marco‐Marín, Cristina Domínguez‐González, et al.. (2017). A newly distal hereditary motor neuropathy caused by a rare AIFM1 mutation. Neurogenetics. 18(4). 245–250. 26 indexed citations
10.
Sancho‐Vaello, Enea, Clara Marco‐Marín, María Leonor Fernández-Murga, et al.. (2016). Understanding N-Acetyl-L-Glutamate Synthase Deficiency: Mutational Spectrum, Impact of Clinical Mutations on Enzyme Functionality, and Structural Considerations. Human Mutation. 37(7). 679–694. 22 indexed citations
11.
Sevilla, Teresa, Vincenzo Lupo, Rafael Sivera, et al.. (2011). Congenital hypomyelinating neuropathy due to a novel MPZ mutation. Journal of the Peripheral Nervous System. 16(4). 347–352. 12 indexed citations
12.
Martinelli, Diego, Johannes Häberle, Vicente Rubio, et al.. (2011). Understanding pyrroline‐5‐carboxylate synthetase deficiency: clinical, molecular, functional, and expression studies, structure‐based analysis, and novel therapy with arginine. Journal of Inherited Metabolic Disease. 35(5). 761–776. 39 indexed citations
13.
Marco‐Marín, Clara & Vicente Rubio. (2008). The site for the allosteric activator GTP of Escherichia coli UMP kinase. FEBS Letters. 583(1). 185–189. 1 indexed citations
14.
Marco‐Marín, Clara, F. Gil-Ortiz, Isabel Pérez‐Arellano, et al.. (2007). A Novel Two-domain Architecture Within the Amino Acid Kinase Enzyme Family Revealed by the Crystal Structure of Escherichia coli Glutamate 5-kinase. Journal of Molecular Biology. 367(5). 1431–1446. 55 indexed citations
15.
Arranz, José Antonio, E. Riudor, Clara Marco‐Marín, & Vicente Rubio. (2007). Estimation of the total number of disease‐causing mutations in ornithine transcarbamylase (OTC) deficiency. Value of the OTC structure in predicting a mutation pathogenic potential. Journal of Inherited Metabolic Disease. 30(2). 217–226. 37 indexed citations
16.
Llacer, J.L., Asunción Contreras, Karl Forchhammer, et al.. (2007). The crystal structure of the complex of P II and acetylglutamate kinase reveals how P II controls the storage of nitrogen as arginine. Proceedings of the National Academy of Sciences. 104(45). 17644–17649. 100 indexed citations
17.
Fresquet, Vicente, et al.. (2005). Understanding Carbamoyl Phosphate Synthetase Deficiency: Impact of Clinical Mutations on Enzyme Functionality. Journal of Molecular Biology. 349(1). 127–141. 31 indexed citations
18.
Marco‐Marín, Clara, F. Gil-Ortiz, & Vicente Rubio. (2005). The Crystal Structure of Pyrococcus furiosus UMP Kinase Provides Insight into Catalysis and Regulation in Microbial Pyrimidine Nucleotide Biosynthesis. Journal of Molecular Biology. 352(2). 438–454. 50 indexed citations
19.
Marco‐Marín, Clara, et al.. (2004). First-time crystallization and preliminary X-ray crystallographic analysis of a bacterial-archaeal type UMP kinase, a key enzyme in microbial pyrimidine biosynthesis. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1747(2). 271–275. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026